Indiana Gov. Mike Braun has signed a nonbinding letter of intent that will see the state’s Office of Energy Development (OED) and Indiana-based pharmaceutical company Eli Lilly collaborate to explore potential nuclear projects.

The focus of these projects—perhaps surprisingly—is not connected to medical radioisotope production. Rather, it will focus on “small modular reactors and other advanced nuclear technologies” that could provide “baseload power for industrial, research, and community uses,” according to the LOI.